annual estimates of the number of individuals who use their insulin pumps (including basic demographic data) the results of clinical research conducted into the human factors associated with newly ...

Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.

You hear it in whispers during bus rides, in clinic waiting rooms, in college corridors. Girls skipping periods for months.

Wir haben maxon besucht und den neuen AIR S Full-Power-Motor unter die Lupe genommen – inkl. exklusiver Einblicke & Testfahrt ...

Multiple developers of connected diabetes hardware have announced plans this week to link their insulin pumps with continuous ...

Investing.com -- Truist Securities launched coverage on four diabetes technology companies, saying there is a long-term growth potential for continuous glucose monitors (CGM) and insulin pumps ...

Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump.

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effective diabetes management tools. Growing awareness ...